Ikuo Yokoyama
Overview
Explore the profile of Ikuo Yokoyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aoyagi T, Ishikawa Y, Oshikawa H, Kinugawa K, Yokoyama I, Nagai R
J Sports Sci Med
. 2014 Apr;
1(4):141-6.
PMID: 24748846
Various substances have been introduced in relation with cardiac hypertrophy almost always with controversy in their roles in signal transduction. Those controversies may attribute to the diversity of cardiac hypertrophy....
2.
Teramoto N, Koshino K, Yokoyama I, Miyagawa S, Zeniya T, Hirano Y, et al.
J Nucl Med
. 2011 Apr;
52(5):761-8.
PMID: 21498524
Unlabelled: A pig model of reduced left ventricular (LV) function and remodeling or chronic heart failure with long survival after myocardial infarction (MI) has not been established. The aim of...
3.
Nomura Y, Inoue Y, Yokoyama I, Nakaoka T, Itoh D, Okubo T, et al.
Magn Reson Imaging
. 2006 Dec;
24(10):1333-9.
PMID: 17145405
The aims of this study were to investigate the applicability of Fourier fitting in the magnetic resonance (MR) evaluation of left ventricular (LV) function and to determine the optimal number...
4.
Seki C, Momose T, Kojima Y, Sasaki Y, Ohtomo K, Yokoyama I
Radiat Med
. 2006 Sep;
24(4):260-8.
PMID: 16958399
Purpose: It is generally assumed that vascular tracer activity is negligible in the quantification of regional cerebral blood flow (rCBF) with H2 15O and positron emission tomography (PET) under normal...
5.
Yokoyama I, Inoue Y, Moritan T, Ohtomo K, Nagai R
Eur J Nucl Med Mol Imaging
. 2006 Mar;
33(6):703-8.
PMID: 16528523
Purpose: Chronic sulphonylurea treatment maintains improved glycaemic control through mechanisms other than enhancement of insulin secretion and may act on various organs. The aim of this study was to investigate...
6.
Yokoyama I, Inoue Y, Moritan T, Ohtomo K, Nagai R
Nucl Med Commun
. 2004 Dec;
26(1):31-7.
PMID: 15604945
Objective: Skeletal muscle glucose utilization (SMGU) can be measured by 18F-FDG PET to characterize insulin resistance. The aim of this study was to determine whether femoral muscle SMGU can be...
7.
Morita H, Yokoyama I, Yamada N, Uno K, Nagai R
Eur J Nucl Med Mol Imaging
. 2004 May;
31(8):1218.
PMID: 15150672
No abstract available.
8.
Inoue Y, Kurimoto S, Kameyama S, Ohta N, Akahane M, Yoshikawa K, et al.
Nucl Med Commun
. 2004 Apr;
25(5):509-13.
PMID: 15100511
Objective: Nephron-sparing surgery is a treatment in which a part of a diseased kidney is resected and some parenchyma of the kidney is spared. Impairment of spared renal parenchyma after...
9.
Yokoyama I, Inoue Y, Moritan T, Ohtomo K, Nagai R
Eur Heart J
. 2004 Apr;
25(8):671-9.
PMID: 15084372
Aims: Impaired myocardial vasodilatation during hyperaemic stress with dipyridamole has been documented in hypercholesterolaemics without evidence of ischaemia. This study investigated whether two commonly used hydroxymethylglutaryl coenzyme A reductase inhibitors,...
10.
Sonoda M, Yonekura K, Yokoyama I, Takenaka K, Nagai R, Aoyagi T
Int J Cardiol
. 2004 Feb;
93(2-3):131-6.
PMID: 14975538
Background: The common carotid intima-media thickness (IMT) is correlated with the angiographically determined coronary artery stenosis. However, their correlation is weak, which limits the clinical application of the IMT as...